
News
Filter Results
Displaying 71–80 of 506
-
Dec 11, 2023
Known as antisense oligonucleotides, the treatments performed encouragingly in ProQR’s clinical trials
-
Nov 29, 2023
Foundation Fighting Blindness Appoints Jeff Klaas as Chief Strategy and Innovation Officer
Klaas brings over twenty years of experience to lead strategies aimed at elevating engagement and revenue.
-
Nov 8, 2023
Kiora Reports Vision Restoration in Phase 1/2 Clinical Trial for Photoswitch Therapy
The company’s molecule is designed to restore some vision to people with ultra-low or no vision caused by advanced retinitis pigmentosa and other retinal diseases.
-
Nov 2, 2023
New Report: Vitamin A Supplementation Provides No Vision Benefit to RP Patients
The report also concludes that vitamin E supplementation accelerates vision loss for RP patients
-
Nov 2, 2023
First of its Kind Collaboration Marries Genomics Data with World’s Largest Database of Ophthalmologic Patient Encounters to Improve Accuracy of Clinical Research.
-
Oct 31, 2023
Foundation Fighting Blindness Named Beneficiary for iDox Concert
Special event being held during American Academy of Ophthalmology annual conference in San Francisco, California
-
Oct 25, 2023
Foundation Fighting Blindness and Eone Announce Partnership
Together, the Foundation Fighting Blindness and Eone are launching a new limited-edition tactile timepiece watch, the ChangeMaker.
-
Sep 18, 2023
Ocugen Reports Updated Results for Clinical Trial of Modifier Gene Therapy
The company is also launching modifier gene therapy clinical trials for GA and Stargardt disease
-
Sep 7, 2023
First Patient Dosed in LCA5 Gene Therapy Clinical Trial Launched by Opus Genetics
Opus was established by the RD Fund, the Foundation’s venture philanthropy arm
-
Sep 7, 2023
Foundation Funds 25 New Grants Totaling $15.1 Million in FY23
The global leader in retinal degenerative disease research supports a total of 93 research grants in its portfolio.